...
首页> 外文期刊>Brain research >Idazoxan increases perforant path-evoked EPSP slope paired pulse inhibition and reduces perforant path-evoked population spike paired pulse facilitation in rat dentate gyrus.
【24h】

Idazoxan increases perforant path-evoked EPSP slope paired pulse inhibition and reduces perforant path-evoked population spike paired pulse facilitation in rat dentate gyrus.

机译:咪唑azo增加大鼠齿状回中穿孔诱导的EPSP斜率对脉冲的抑制作用,并降低穿孔诱导的种群尖峰对的脉冲促成作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Norepinephrine, acting via beta-adrenoceptors, enhances the perforant path-evoked potential in dentate gyrus. Using systemic idazoxan to increase norepinephrine, and paired perforant path pulses to probe early inhibition, previous investigators reported that idazoxan increased initial spike amplitude and increased somatic feedback inhibition. Here, feedback inhibition was re-examined in idazoxan-treated (5 mg/kg) rats under urethane anesthesia. To control for initial increased spike amplitude after idazoxan, evoked potentials were matched, pre- and post-idazoxan, on initial population spike. Input-output current profiles were also compared pre- and post-idazoxan. Saline- and timolol-filled micropipettes permitted evaluation of a contribution of local beta-adrenoceptors. As previously observed, initial spike amplitude was potentiated by idazoxan. Comparable spike potentiation was not seen on the timolol micropipette. Paired pulse inhibition of spike amplitude apparently increased, but input-output curvecomparisons revealed a loss of feedback facilitation rather than an increase in feedback inhibition. Initial EPSP slopes were depressed after idazoxan in input-output curve data. EPSP slope feedback ratios were significantly reduced following idazoxan.These data suggest idazoxan has multiple effects on perforant path input to the dentate gyrus. Spike potentiation following idazoxan has previously been shown to depend on intact norepinephrine input. Here, the reduction in spike potentiation on the timolol pipette is consistent with other evidence that norepinephrine-mediated potentiation of the perforant path-evoked potential is dependent on local beta-adrenoceptor activation. The input-output data suggest a decrease in feedback facilitation after idazoxan is likely to account for the apparent increase in feedback inhibition previously reported. Decreased EPSP slope ratios with similar paired pulse intervals have been reported in novel environments. Since exposure to novel environments activates locus coeruleus neurons, norepinephrine may mediate the change in EPSP slope inhibition reported in awake rats.In summary, these results are consistent with the hypothesis that idazoxan potentiates granule cell responses to perforant path input in the dentate gyrus via increases in norepinephrine that lead to beta-adrenoceptor activation, and, further, that idazoxan reduces paired pulse feedback spike facilitation and enhances EPSP slope, but not spike, feedback inhibition.
机译:去甲肾上腺素通过β-肾上腺素受体起作用,增强了齿状回的穿孔路径诱发电位。以前的研究人员报道,使用全身性的伊达沙生增加去甲肾上腺素,并配对穿孔路径脉冲以探测早期抑制作用,以前的研究者报道,伊达沙生增加了初始刺突幅度并增加了体反馈抑制。在此,在氨基甲酸乙酯麻醉下,对接受咪唑x吨治疗的大鼠(5 mg / kg)进行了反馈抑制的重新检查。为了控制在偶氮唑烷后初始的尖峰幅度增加,在最初的种群尖峰时,在偶氮唑烷之前和之后将诱发电位相匹配。输入-输出电流曲线也进行了偶氮唑烷前后的比较。盐水和替莫洛尔填充的微量移液器可以评估局部β-肾上腺素能受体的贡献。如先前观察到的那样,初始尖峰幅度被咪唑烷增强。在噻吗洛尔微量移液器上未观察到可比的穗增强。成对脉冲对尖峰幅度的抑制作用明显增加,但是输入-输出曲线比较显示出反馈促进作用的丧失而不是反馈抑制作用的增加。依达唑烷在输入-输出曲线数据中后,初始EPSP斜率下降。吡唑烷后,EPSP斜率反馈比率显着降低,这些数据表明吡唑烷对齿状回的穿孔路径输入有多种影响。先前已证明依达唑烷后的穗增强作用取决于完整的去甲肾上腺素输入。在这里,噻吗洛尔移液器上的穗电位增强的减少与其他证据表明,去甲肾上腺素介导的穿孔路径诱发电位的增强取决于局部β-肾上腺素受体的激活。输入-输出数据表明,在使用偶氮唑烷可能解释了先前报道的反馈抑制作用明显增加后,反馈促进作用降低了。在新颖的环境中,已经报道了具有相似的成对脉冲间隔的EPSP斜率降低。由于暴露于新的环境中会激活蓝藻所在地的神经元,因此去甲肾上腺素可能介导清醒大鼠中EPSP斜率抑制的变化。总而言之,这些结果与以下假设相符:伊达唑烷通过增加而增强了对齿状回穿孔路径输入的颗粒细胞反应。去甲肾上腺素中导致β-肾上腺素能受体激活的作用,此外,依达唑烷可降低配对脉冲反馈的尖峰促进作用,并增强EPSP斜率,但不增强尖峰反馈抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号